ProMis Neurosciences, Inc

Nasdaq PMN · Toronto, Ontario, Canada

Works in Neurology · Psychiatry

ProMis Neurosciences, Inc is a clinical trial sponsor based in Toronto, Ontario, Canada, listed as Nasdaq PMN. It has 1 active clinical trial with 144 planned participants, in Neurology and Psychiatry. Since 2021 it has completed 1 trial and stopped 0 early.

Trial track record · since 2021

1Active trials144 planned participants
1Completed1 with results posted
0Stopped earlyterminated, withdrawn or suspended

Financials · Nasdaq PMN

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 1 active trial

StageTrialStatus

Questions about ProMis Neurosciences, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-13.

Approve Suite is not affiliated with ProMis Neurosciences, Inc.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.